A new partially covered nitinol stent for palliative treatment of malignant bile duct obstruction: a multicenter single-arm prospective study

Background and study aims: Covered self-expanding metal stents (SEMSs) have proven effective for managing malignant bile duct strictures and may reduce risk of tumor ingrowth. A new nitinol partially covered biliary SEMS was prospectively evaluated.

Patients and methods: 70 patients with inoperable extrahepatic biliary obstructions were enrolled in a prospective multicenter trial, and followed up to 6 months or death, whichever came first. Primary endpoint was adequate palliation defined as absence of recurrent biliary obstruction from partly covered SEMS placement to end of follow-up.

Results: Mean age of the patients was 69 years and 52 % were men. Pancreatic carcinoma was present in 68 %. One stent was placed in 67 patients, two patients received two, and in one patient a guide wire could not traverse the stricture. In 55 % of patients the SEMS was inserted de novo and in 45 % for exchange with a plastic stent. Technical success was 97 %. At 6 months, 62 % of patients were free of obstructive symptoms; compared with baseline the mean number of symptoms per patient was significantly reduced (3.1 at baseline, 0.6 at 6 months; P < 0.0001) and total bilirubin levels dropped by 73 %. There were four cases of recurrent biliary obstruction, due to stent migration (2), tumor overgrowth (1), and sludge formation (1). Device-related complications included cholecystitis (3), right upper quadrant pain (1), and moderate pancreatitis (1). No tumor ingrowth was reported.

Conclusions: This new partially covered nitinol SEMS is easily inserted, and safe and effective in the palliation of biliary obstruction secondary to malignant bile duct strictures.

References

• 1 Moss A C, Morris E, Leyden J et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction.  Eur J Gastroenterol Hepatol. 2007;  19 1119-1124
• 2 Weber A, Mittermeyer T, Wagenpfeil S et al. Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer.  Pancreas. 2009;  38 e7-e12
• 3 Schmassmann A, von Gunten E, Knuchel J et al. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival.  Am J Gastroenterol. 1996;  91 654-659
• 4 Menon K, Romagnuolo J, Barkun A N. Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion.  Am J Gastroenterol. 2001;  96 1435-1440
• 5 Yeoh K G, Zimmerman M J, Cunningham J T et al. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis.  Gastrointest Endosc. 1999;  49 466-471
• 6 Arguedas M R, Heudebert G H, Stinnett A A et al. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis.  Am J Gastroenterol. 2002;  97 898-904
• 7 Kaassis M, Boyer J, Dumas R et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study.  Gastrointest Endosc. 2003;  57 178-182
• 8 Katsinelos P, Paikos D, Kountouras J et al. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness.  Surg Endosc.. 2006;  20 1587-1593
• 9 Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial.  Gastrointest Endosc. 2006;  63 986-995
• 10 Davids P H, Groen A K, Rauws E A et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.  Lancet. 1992;  340 1488-1492
• 11 Bueno J T, Gerdes H, Kurtz R C. Endoscopic management of occluded biliary Wallstents: a cancer center experience.  Gastrointest Endosc. 2003;  58 879-884
• 12 Isayama H, Komatsu Y, Tsujino T et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction.  Gastrointest Endosc. 2002;  55 366-370
• 13 Isayama H, Komatsu Y, Tsujino T et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction.  Gut. 2004;  53 729-734
• 14 Yoon W J, Lee J K, Lee K H et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction.  Gastrointest Endosc. 2006;  63 996-1000
• 15 Han Y M, Kwak H S, Jin G Y et al. Treatment of malignant biliary obstruction with a PTFE-covered self-expandable nitinol stent.  Korean J Radiol. 2007;  8 410-417
• 16 Dumonceau J M, Cremer M, Auroux J et al. A comparison of Ultraflex Diamond stent and Wallstent for palliation of distal malignant strictures.  Am J Gastroenterol. 2000;  95 670-676
• 17 Shah R J, Somogyi L, Petersen B T et al. Short-wire ERCP systems.  Gastrointest Endosc. 2007;  66 650-657
• 18 Ornellas L C, Stefanidis G, Chuttani R et al. Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention.  Gastrointest Endosc.. 2009;  70 676-683
• 19 Yoon W J, Ryu J K, Yang K Y et al. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost.  Gastrointest Endosc. 2009;  70 284-289
• 20 Born P, Neuhaus H, Rösch T et al. Initial experience with a new, partially covered Wallstent for malignant biliary obstruction.  Endoscopy. 1996;  28 699-702
• 21 Hausegger K A, Thurnher S, Bodendörfer G et al. Treatment of malignant biliary obstruction with polyurethane-covered Wallstents.  AJR Am J Roentgenol. 1998;  170 403-408
• 22 Familiari P, Bulajic M, Mutignani M et al. Endoscopic removal of malfunctioning biliary self-expandable metallic stents.  Gastrointest Endosc. 2005;  62 903-910
• 23 Christiaens P, Decock S, Buchel O et al. Endoscopic trimming of metallic stents with the use of argon plasma.  Gastrointest Endosc.. 2008;  67 369-371
• 24 Suk K T, Kim H S, Kim J W et al. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction.  Gastrointest Endosc. 2006;  64 522-529
• 25 Isayama H, Kawabe T, Nakai Y et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction.  Clin Gastroenterol Hepatol. 2006;  4 1148-1153
• 26 Fumex F, Coumaros D, Napoleon B et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation.  Endoscopy. 2006;  38 787-792
• 27 Nakai Y, Isayama H, Kawabe T et al. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.  Pancreas.. 2008;  37 405-410